系统性炎症响应指数,一种潜在的炎症生物标志物在疾病严重程度的肌痛性严重性:一个试点回顾性研究
Suwen Huang1, Yanchu Wang1,2, Jinrong Zhu1,3
1Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Journal of inflammation research
|April 30, 2024
概括
系统性炎症反应指数 (SIRI) 是评估肌痛性骨髓灰质炎 (MG) 严重程度的潜在生物标志物. 这项研究发现SIRI与MG疾病严重程度有很强的相关性,并且比现有的标志物提供更好的临床益处.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 骨髓灰质炎 (MG) 是一种慢性自身免疫性神经肌肉结合障碍,其炎症成分不明.
- 系统性炎症反应指数 (SIRI) 是一种新兴的炎症生物标志物,但其在MG严重程度评估中的作用尚未被探索.
研究的目的:
- 调查SIRI与肌痛性骨髓灰质炎患者的疾病严重程度之间的关联.
- 评估SIRI作为MG严重程度的潜在生物标志物,与已确定的指标相比.
主要方法:
- 对143名肌痛性骨髓灰质炎患者的临床数据进行了回顾性分析.
- 使用MGFA分类和MG-ADL评估的疾病严重程度.
- 后勤回归,ROC曲线和DCA用于分析SIRI与严重程度的关联.
主要成果:
- 在高和低MG疾病严重程度组之间,SIRI水平显著不同 (p < 0.001).
- SIRI显示出与高MG疾病严重程度 (OR = 1.308,p = 0.008) 有显著的独立关联,并与MG-ADL (r = 0.232,p = 0.008) 有积极的相关性.
- 决策曲线分析表明,与其他标记物相比,SIRI具有更高的临床实用性.
结论:
- SIRI是一种强有力的,独立的预测器,可预测肌痛性骨髓灰质炎的疾病严重程度.
- SIRI显示出作为MG有价值的生物标志物的潜力,比目前的标志物提供更强大的临床益处.
更多相关视频
06:29Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
26.3K
08:05Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017
9.2K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
800
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
800
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
